Medigen Biotechnology (3176) — Free Cash Flow Generation Index
Medigen Biotechnology (3176) has a Free Cash Flow Generation Index of 0.94x as of December 2024. Free cash flow of NT$147.66 Million represents 1% of operating cash flow (NT$156.75 Million). See working capital to net assets of Medigen Biotechnology to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Medigen Biotechnology Free Cash Flow Generation Index (2003–2024)
Historical FCF Generation Index trend for Medigen Biotechnology across 5 annual periods. Explore debt repayment capacity of Medigen Biotechnology to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Medigen Biotechnology (2003–2024)
Year-by-year Free Cash Flow Generation Index for Medigen Biotechnology. For the full company profile including market capitalisation, see 3176 market cap overview.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.55x | NT$-20.76 Million | NT$37.92 Million | NT$58.68 Million | ▼ -176.0% |
| 2021 | 0.72x | NT$372.90 Million | NT$517.45 Million | NT$144.55 Million | ▼ -73.8% |
| 2015 | 2.75x | NT$809.42 Million | NT$294.18 Million | NT$515.25 Million | ▲ +164.6% |
| 2005 | 1.04x | NT$83.93 Million | NT$80.72 Million | NT$3.21 Million | ▲ +3.1% |
| 2003 | 1.01x | NT$449.42 Million | NT$445.46 Million | NT$3.96 Million | — |